The influence of apoprotein ε2 homozygosity on nephrotic hyperlipidemia

Clinical Nephrology

Volumn 48, Issue 3, 1997, Pages 141-145

  Joven, J ^a   Vilella, E ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Apoprotein E; Atherogenicity; Lipoproteins; Nephrotic syndrome; Proteinuria

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E2; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; APOLIPOPROTEIN; APOLIPOPROTEIN E; CHYLOMICRON;

ADULT; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; HOMOZYGOSITY; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; NEPHROTIC SYNDROME; PROTEINURIA; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; GENETICS; HOMOZYGOTE; HYPERLIPIDEMIA;

ADULT; APOLIPOPROTEIN E2; APOLIPOPROTEINS; APOLIPOPROTEINS E; CHOLESTEROL; CHYLOMICRONS; HOMOZYGOTE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEIN LIPASE; LIPOPROTEIN(A); MALE; NEPHROTIC SYNDROME; TRIGLYCERIDES;

EID: 0030613546     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Baxter JH, Goodman HC, Havel RJ 1960 Serum lipid and lipoprotein alterations in nephrosis. J Clin Invest 39: 455-465
2. Beaumont JL, Cartson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T 1970 Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ 43: 891-915
3. Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing CF 1987 The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of apolipoprotein E polymorphism in determining levels, variability and covariability of cholesterol, beta-lipoprotein and triglycerides in a sample of unrelated individuals. Am J Hum Genet 27: 567-582
4. Davignon J, Gregg RE, Sing CF 1988 Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21
5. Djamali A, Cristol JP, Turc-Baron C, Beucier I, Baldet P, Mourad G 1996 Glomerulopathie lipoproteinique: un nouveau cas francais avec recidive sur le transplant. Presse Med 25: 798-802
6. Ehnholm C, Lukka M, Kuusi T, Nikkila E, Utermann G 1986 Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 27: 227-235
7. Ellis D, Orchard T, Lombardozzi S, Edwardo J, McCauley J, Agostini R, Diamond J 1995 Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity. J Am Soc Nephrol 6: 1170-1177
8. Eto M, Watanabe K, Makino I, Ishi K 1991 Apolipoprotein E allele frequencies in non-insulin dependent diabetes mellitus with hypertriglyceridemia (type IIb, III, IV and V hyperlipoproteinemia). Metabolism 40: 776-780
9. Gherardi E, Rota E, Calandra S, Genova R, Tamborino A 1977 Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome. Eur J Clin Invest 7: 563-570
10. Joven J, Vilella E, Costa B, Turner P, Richart C, Masana L 1989 Concentrations of lipids and apolipoproteins in patients with well-controlled insulin-dependent and non-insulin dependent diabetes. Clin Chem 35: 813-816
11. Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M 1990 Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med 323: 579-584
12. Joven J, Villabona C. Vilella E 1993 Pattern of hyperlipoproteinemia in human nephrotic syndrome: influence of renal failure and diabetes mellitus. Nephron 64: 565-569
13. Joven J, Vilella E, Ahmad S, Cheung MC, Brunzell JD 1993 Lipoprotein heterogeneity in end-stage renal disease. Kidney Int 43: 410-418
14. Joven J. Simó JM, Vilella E, Camps J, Espinel E, Villabona C 1995 Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria. Clin Chem 41: 908-913
15. Joven J, Espinel E, Simó JM, Vilella E, Camps J, Oliver A 1996 The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia. Atherosclerosis 126: 243-252
16. Kashyap ML, Srivastava LS, Hynd BA et al. 1980 Apolipoprotein C II and lipoprotein lipase in human nephrotic syndrome. Atherosclerosis 35: 29-40
17. Keane WF, Kasiske BL, O'Donnell MP 1988 Lipids and progressive glomerulosclerosis: a model analogous to atherosclerosis. Am J Nephrol 8: 261-271
18. Keane WF, Peter JV, Kasiske BL 1992 Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory? Kidney Int 42 (Suppl 38): 134-141
19. Kramer A, Nauck M, Pavenstadt H, Schwedler S, Wieland H, Schollmeyer P, Wanner C 1993 Receptor mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells. Kidney Int 44: 1341-1351
20. Kramer A, Nauck M, Pavenstadt H, Koniger M, Wieland H, Schollmeyer P, Wanner C 1994 Preferential uptake of intermediatedensity-lipoproteins from nephrotic patients by human mesangial and liver cells. J Am Soc Nephrol 5: 1081-1090
21. Mahley RW, Rail SC 1996 Type III hyperlipoproteinemia (dysbetalipoproteinemia). The role of apolipoprotein E in normal and abnormal lipoprotein metabolism, in The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly W and Volle D, New York, McGraw Hill, pp 1993-1953
22. Muls E, Rosseneu M, Daneels R, Schurgess M, Boelaert J 1985 Lipoprotein distribution and composition in the human nephrotic syndrome. Atherosclerosis 54: 225-237
23. Ongkingco JRC, Mann WA, Ruley EJ, Gregg RE 1991 Severe hypertriglyceridemia due to multiple factors in a child with nephrotic syndrome. Child Nephrol Urol 11: 107-110
24. Parhofer KG, Richter WO, Schwandt P 1990 Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia. Horm Metab Res 22: 589-594
25. Sato H, Suzuki S, Kobayashi H, Ogino S, Inomata A, Arakawa M 1991 Immunohistological localization of apolipoproteins in the glomeruli in renal disease, specifically apo B and apo E. Clin Nephrol 36: 127-133
26. Simó J, Bertran N, Juanpere M, Camps J, Joven J 1989 Evaluación preliminar del analizador automático Monarch 2000. Quim Clin 8: 329-335
27. Sing CF, Davignon J 1985 Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37: 268-285
28. Utermann G, Jaeschke M, Menzel J 1975 Familial hyperlipoproteinemia type III. Deficiency of a specific apolipoprotein (apo E III) in the very low density lipoproteins. FEBS lett 56: 352-355
29. Vega GL, Toto RD, Grundy SM 1995 Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia. Kidney Int 47: 579-586
30. Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H 1993 Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med 119: 263-269